Unibest
← Back to patent-cliff list

CAS 920271-16-5

1-(palmitoyloxy)-3-(trityloxy)propan-2-yl (9Z,12Z)-octadeca-9,12-dienoate

Codes: EC-18-004

Application context (from source-drug indications)

Atopic dermatitisMosedipimodCOVID-19Mosedipimod发热性中性粒细胞减少症MosedipimodStomatitisMosedipimodNeutropeniaMosedipimod

Source drugs (routes using this intermediate)

DrugTierExpiry
MosedipimodTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

MosedipimodOriginator routesteps: 3total yield: 63.5 g
1-acetoxy-3-(palmitoyloxy)propan-2-yl (9Z,12Z)-octadeca-9,12-dienoate→2,3-dihydroxypropyl palmitate→2-hydroxy-3-(trityloxy)propyl palmitate→(9Z,12Z)-octadeca-9,12-dienoic acid→1-(palmitoyloxy)-3-(trityloxy)propan-2-yl (9Z,12Z)-octadeca-9,12-dienoate

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.